Two Sigma Investments’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-10,586
| Closed | -$14.5K | – | 2938 |
|
2023
Q2 | $14.5K | Sell |
10,586
-7,000
| -40% | -$9.59K | ﹤0.01% | 2850 |
|
2023
Q1 | $41.5K | Sell |
17,586
-4,051
| -19% | -$9.56K | ﹤0.01% | 2704 |
|
2022
Q4 | $49.3K | Sell |
21,637
-8,100
| -27% | -$18.5K | ﹤0.01% | 2534 |
|
2022
Q3 | $82K | Sell |
29,737
-1,400
| -4% | -$3.86K | ﹤0.01% | 2206 |
|
2022
Q2 | $76K | Sell |
31,137
-37,349
| -55% | -$91.2K | ﹤0.01% | 2231 |
|
2022
Q1 | $270K | Sell |
68,486
-56,707
| -45% | -$224K | ﹤0.01% | 2205 |
|
2021
Q4 | $552K | Buy |
125,193
+9,869
| +9% | +$43.5K | ﹤0.01% | 1943 |
|
2021
Q3 | $713K | Buy |
115,324
+57,814
| +101% | +$357K | ﹤0.01% | 1860 |
|
2021
Q2 | $455K | Buy |
57,510
+19,941
| +53% | +$158K | ﹤0.01% | 1998 |
|
2021
Q1 | $402K | Buy |
+37,569
| New | +$402K | ﹤0.01% | 1955 |
|